Inventor
ACTON III JOHN J
US16 patents
⚠️ This page may combine multiple inventors who share the name “ACTON III JOHN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
7 patentsUS5719296AFeb 17, 1998
Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
MERCK & CO INC112 citations95
US6852738B2Feb 8, 2005
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
MERCK & CO INC32 citations91
US6525083B2Feb 25, 2003
N-substituted indoles useful in the treatment of diabetes
MERCK & CO INC47 citations84
US7186746B2Mar 6, 2007
Indoles having anti-diabetic activity
MERCK & CO INC14 citations82
US7393960B2Jul 1, 2008
Indoles having anti-diabetic activity
MERCK & CO INC7 citations73
US7345085B2Mar 18, 2008
Indoles having anti-diabetic activity
MERCK & CO INC8 citations72
US5506262AApr 9, 1996
Cholesterol lowering compounds
MERCK & CO INC7 citations60
MERCK SHARP & DOHME
4 patentsUS10933056B2Mar 2, 2021
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
MERCK SHARP & DOHME2 citations71
US9353101B2May 31, 2016
Cyclic amine substituted heterocyclic CETP inhibitors
MERCK SHARP & DOHME3 citations71
US11339156B2May 24, 2022
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
MERCK SHARP & DOHME0 citations49
US9650375B2May 16, 2017
Indole derivatives useful as anti-diabetic agents
MERCK SHARP & DOHME0 citations40
MERCK SHARP & DOHME LLC
4 patentsUS12030872B2Jul 9, 2024
N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC2 citations69
US11970479B2Apr 30, 2024
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
MERCK SHARP & DOHME LLC0 citations50
US12319671B2Jun 3, 2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations48
US12570640B2Mar 10, 2026
2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations46